Skip to main content

Table 3 The NRI and IDI were used to assess reclassification performance and improvement in discrimination of our novel prediction model

From: A novel clinical model for predicting malignancy of solitary pulmonary nodules: a multicenter study in chinese population

 

NRI

P Value

IDI

P Value

Training cohort

 Our model vs. PKUPH model

0.177

0.005

− 0.019

0.433

 Our model vs. Shanghai model

0.127

0.058

− 0.076

0.005

 Our model vs. Mayo model

0.396

< 0.001

0.112

< 0.001

External validation cohort

 Our model vs. PKUPH model

-0.035

0.726

− 0.043

0.341

 Our model vs. Shanghai model

0.027

0.769

− 0.017

0.709

 Our model vs. Mayo model

0.249

0.008

0.086

< 0.001

  1. NRI net reclassification improvement index, IDI integrated discrimination improvement index